Literature DB >> 15141860

Future considerations for the medical management of nerve-agent intoxication.

Pål Aas1.   

Abstract

The use of chemical warfare agents against civilians and unprotected troops in international conflicts or by terrorists against civilians is considered to be a real threat, particularly following the terrorist attacks on 11 September 2001 against the World Trade Center in New York and against the Pentagon in Washington, DC. Over the past 10 years, terrorists have been planning to use or have used chemical warfare agents on several occasions around the world, and the attacks in 2001 illustrate their willingness to use any means of warfare to cause death and destruction among civilians. In spite of new international treaties with strong verification measures and with an aim to prohibit and prevent the use of weapons of mass destruction, nevertheless, some countries and terrorist groups have been able to develop, produce, and use such weapons, particularly nerve agents, in domestic terrorist attacks or during warfare in international conflicts. This article reviews current medical therapy for nerve-agent intoxication and discusses possible future improvement of medical therapies. Present medical counter-measures against nerve agents are not sufficiently effective particularly in protecting the brain. Therefore, new and more effective countermeasures must be developed to enable better medical treatment of civilians and military personnel following exposure to nerve agents. Therefore, it is important with an enhanced effort by all countries, to improve and increase research in medical countermeasures, in the development of protective equipment, and in carrying out regular training of medical and emergency personnel as well as of military nuclear, biological, or chemical (NBC) units. Only then will nations be able to reduce the risk from and prevent the use of such weapons of mass destruction (WMD).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15141860     DOI: 10.1017/s1049023x00001072

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  7 in total

Review 1.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

Review 2.  Oxime-mediated reactivation of organophosphate-inhibited acetylcholinesterase with emphasis on centrally-active oximes.

Authors:  Janice E Chambers; Mary B Dail; Edward C Meek
Journal:  Neuropharmacology       Date:  2020-06-13       Impact factor: 5.250

3.  Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.

Authors:  Patrick Masson; Daniel Rochu
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

4.  Protection studies of new bis quaternary 2-(hydroxyimino)-N-(pyridin-3yl) acetamide derivatives (HNK-series) oximes against acute poisoning by dichlorvos (DDVP) in Swiss albino mice.

Authors:  Pravin Kumar; Devyani Swami; Hitendra N Karade; Manindar Singh; Anupma Tiwari; Kshetra Pal Singh
Journal:  Interdiscip Toxicol       Date:  2017-05-17

Review 5.  A Triage Model for Chemical Warfare Casualties.

Authors:  Mohammad Ali Khoshnevis; Yunes Panahi; Mostafa Ghanei; Hojat Borna; Amirhossein Sahebkar; Jafar Aslani
Journal:  Trauma Mon       Date:  2015-08-01

6.  Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes.

Authors:  Golime RamaRao; Prachiti Afley; Jyothiranjan Acharya; Bijoy Krishna Bhattacharya
Journal:  BMC Neurosci       Date:  2014-04-04       Impact factor: 3.288

7.  Behavioral side effects of prophylactic therapies against soman-induced seizures and lethality in rats.

Authors:  Trond Myhrer; Siri Enger; Pål Aas
Journal:  Toxicol Rep       Date:  2014-05-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.